AllianceBernstein
CRBU icon

AllianceBernstein’s Caribou Biosciences CRBU Stock Holding History

AllianceBernstein’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-171,560
Closed -$157K – 3255
2025
Q1 		$157K Hold
171,560
– – ﹤0.01% 2983
2024
Q4 		$273K Hold
171,560
– – ﹤0.01% 2922
2024
Q3 		$336K Hold
171,560
– – ﹤0.01% 2864
2024
Q2 		$281K Buy
171,560
+86,930
+103% +$278K ﹤0.01% 2938
2024
Q1 		$435K Sell
84,630
-1,130
-1% -$6.97K ﹤0.01% 2640
2023
Q4 		$491K Buy
85,760
+17,810
+26% +$88K ﹤0.01% 2617
2023
Q3 		$325K Hold
67,950
– – ﹤0.01% 2781
2023
Q2 		$289K Buy
67,950
+28,350
+72% +$127K ﹤0.01% 2881
2023
Q1 		$210K Buy
39,600
+4,300
+12% +$26.8K ﹤0.01% 2889
2022
Q4 		$222K Buy
35,300
+5,500
+18% +$48.9K ﹤0.01% 2975
2022
Q3 		$314K Buy
29,800
+4,700
+19% +$43.8K ﹤0.01% 2843
2022
Q2 		$136K Buy
+25,100
New +$192K ﹤0.01% 3090
2021
Q4 		– Sell
-24,488
Closed -$585K – 3303
2021
Q3 		$585K Buy
+24,488
New +$599K ﹤0.01% 2703

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein's CRBU Position: Q2 2025 in Review

AllianceBernstein sold out of Caribou Biosciences (CRBU) in Q2 2025, closing a stake of 171,560 shares — an estimated $157K sold.

AllianceBernstein first reported a position in CRBU in Q3 2021 and held it in 13 quarters. The position peaked at $585K in Q3 2021. 129 funds tracked by Wall St. Rank hold CRBU as of Q2 2025.

  • AllianceBernstein reported no remaining Caribou Biosciences position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 171,560 Caribou Biosciences shares in Q2 2025, an estimated $157K.
  • AllianceBernstein first reported a position in Caribou Biosciences in Q3 2021 and held it in 13 quarters.
  • AllianceBernstein's Caribou Biosciences position peaked at $585K in Q3 2021.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.